Christophe ALMERAS

Dr. Christophe ALMERAS

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Guillaume PloussardGuillaume Ploussard
Guillaume Ploussard
JBJean-Baptiste Beauval
Jean-Baptiste Beauval
RRRaphaële Renard-Penna
Raphaële Renard-Penna
MLMarine Lesourd
Marine Lesourd
CMCécile Manceau
Cécile Manceau
MRMathieu Roumiguie
Mathieu Roumiguie
Background: To study the impact of MRI characteristics and of targeted biopsy (TB) core number on the final grade group (GG) prediction. Materials and Methods: The cohort was 478 consecutive patients who underwent radical prostatectomy (RP) after positive mpMRI (multiparametric magnetic resonance imaging) followed by fusion TB. Endpoints were the upgrading and concordance rates between TB and RP specimens. Results: Upgrading rate after TB was 40.6%. Patients with upgrading had lower PIRADS (Prostate Imaging-Reporting and Data System) scores (p < 0.001), smaller lesion size (p = 0.017), fewer TB cores (p < 0.001), and lower TB density (p = 0.015) compared with cases with grade concordance. There was a significant continuous improvement in upgrading rate when TB core number per lesion increased from 56.3% to 25.6% when <2 or ≥5 TB cores were taken, respectively (p = 0.002). The minimal TB number per lesion to reduce upgrading risk to approximately 30%was 4 in PIRADS 3, and 3 in PIRADS 4–5 cases. Conclusions: Grade group prediction by TB is significantly improved by higher PIRADS score, larger lesion size, and increased TB per lesion. At least four TB cores should be taken in PIRADS 3 score lesions, whereas three cores seem enough in PIRADS 4–5 cases to improve GG prediction and limit upgrading risk.


26 November 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CMCécile Manceau
Cécile Manceau
JBJean-Baptiste Beauval
Jean-Baptiste Beauval
MLMarine Lesourd
Marine Lesourd
CAChristophe ALMERAS
Christophe ALMERAS
RARichard Aziza
Richard Aziza
Guillaume PloussardGuillaume Ploussard
Guillaume Ploussard
Background: After radical prostatectomy (RP), biochemical recurrence (BCR) is associated with an increased risk of developing distant metastasis and prostate cancer specific and overall mortality. Methods: The two-centre study included 521 consecutive patients undergoing RP for positive pre-biopsy magnetic resonance imaging (MRI) and pathologically proven prostate cancer (PCa), after which a combination scheme of fusion-targeted biopsy (TB) and systematic biopsy was performed. We assessed correlations between MRI characteristics, International Society of Urological Pathology (ISUP) grade group in TB, and outcomes after RP. We developed an imaging-based risk classification for improving BCR prediction. Results: Higher Prostate Imaging and Reporting and Data System (PI-RADS) score (p = 0.013), higher ISUP grade group in TB, and extracapsular extension (ECE) on the MRI were significantly associated with more advanced disease (pTstage), higher ISUP grade group (p = 0.001), regional lymph nodes metastasis in RP specimens (p < 0.001), and an increased risk of recurrence after surgery. A positive margin status was significantly associated with ECE-MRI (p < 0.001). Our imaging-based classification included ECE on MRI, ISUP grade group on TB, and PI-RADS accurately predicted BCR (AUC = 0.714, p < 0.001). This classification had more improved area under the curve (AUC) than the standard d’Amico classification in our population. Validation was performed in a two-centre cohort. Conclusions: In this cohort, PI-RADS score, MRI stage, and ISUP grade group in MRI-TB were significantly predictive for disease features and recurrence after RP. Imaging-based risk classification integrating these three factors competed with d’Amico classification for predicting BCR.

31 October 2023 in Progrès en Urologie
Verified
Journal Article
Closed access
MDMichel Daudon
Michel Daudon
JHJean-Philippe HAYMANN
Jean-Philippe HAYMANN
VEV. Estrade
V. Estrade
PMP. Meria
P. Meria
CAChristophe ALMERAS
Christophe ALMERAS

31 March 2016 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
CAChristophe ALMERAS
Christophe ALMERAS
MDMichel Daudon
Michel Daudon
GPGuillaume Ploussard
Guillaume Ploussard
JGJean Romain Gautier
Jean Romain Gautier
Olivier TraxerOlivier Traxer
Olivier Traxer
PMPaul Meria
Paul Meria

31 October 2023 in Progrès en Urologie
Verified
Journal Article
Closed access
FPF. Panthier
F. Panthier
NAN. Abid
N. Abid
AHA. Hoznek
A. Hoznek
OTO. Traxer
O. Traxer
PMP. Meria
P. Meria
CAChristophe ALMERAS
Christophe ALMERAS